ArticleScientific reports2025
Effect of metformin on the level of aqueous humor inflammatory cytokines in patients with cataract.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The association between glycated hemoglobin and intraocular inflammatory factors in patients with proliferative diabetic retinopathy.International journal of retina and vitreous · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
This study investigated the content of inflammatory cytokines in the aqueous humor (AH) of cataract patients with type 2 diabetes (T2DM) and explored the effect of metformin on the level of cytokines. AH was collected from patients undergoing phacoemulsification and intraocular lens implantation in Peking University Third Hospital. Levels of cytokines were measured by Cytometric Bead Assay (CBA) Flex Set. Differences in level of AH cytokines were compared between patients using metformin and non-metformin medicine as blood sugar control drug for T2DM and age-related cataract patients without T2DM. A total of 67 patients were included, including 19 healthy controls, 33 patients in the metformin group, and 15 patients in the non-metformin group. The results showed that IL-6 levels were significantly higher in the non-metformin group than the metformin group and the healthy control group (p = 0.019 and 0.014, respectively). IFN-γ levels were also significantly higher in the non-metformin group than the metformin group and the healthy control group (p = 0.031 and 0.003, respectively). The levels of IL-10 in non-metformin group were significantly higher than those in the healthy control group (p = 0.008), whereas the levels of IL-10 showed no significant difference between metformin group and healthy controls. Metformin can reduce the level of cytokines in AH to a certain extent in cataract patients combined with T2DM. It is suggested that metformin may have preventive and therapeutic effects on the development of age-related cataract.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.